Surrogates, substudies, and real clinical end points in trials of drug-eluting stents
- 19 April 2005
- journal article
- editorial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 45 (8), 1206-1212
- https://doi.org/10.1016/j.jacc.2005.01.005
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studiesJournal of the American College of Cardiology, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): A four-year follow-upJournal of the American College of Cardiology, 1999
- Heparin-Coated Palmaz-Schatz Stents in Human Coronary ArteriesCirculation, 1996
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994
- Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1993
- Changing incidence and management of abrupt closure following coronary intervention in the new device eraCatheterization and Cardiovascular Diagnosis, 1992
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992